Celltrion Inc. said Monday that Singapore's state investment firm Temasek Holdings will invest $129 million in the company, a move that will likely make it easier for the Korean biotechnology firm's founder to exit the company.
Temasek bought one million shares in Celltrion Inc. from Celltrion Holdings and its logistics arm Celltrion GSC after markets closed Monday, and will buy more later, Celltrion Inc. said in a statement, adding that Temasek's total investment will amount to 150 billion won. The sellers will use the proceeds to pay back debt. Full story
Related:
